Expression and characterization of anti-NCA-95 scFv (CEA 79 scFv) in a prokaryotic expression vector modified to contain a Sfi I and not I site

Hybridoma

Volumn 18, Issue 3, 1999, Pages 243-249

  Yi, Kyesook ^a   Chung, Junho ^b   Kim, Hyojung ^b   Kim, Ikjung ^b   Jung, Hyanggi ^b   Kim, Jungran ^b   Choi, Inhak ^c   Suh, Pannghill ^a   Chung, Hongkeun ^d  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

^c Inje University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY;

ARTICLE; BACTERIOPHAGE; BONE MARROW; CELL INCLUSION; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE EXPRESSION; GRANULOCYTE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BASE SEQUENCE; CARCINOEMBRYONIC ANTIGEN; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA PRIMERS; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VECTORS; GRANULOCYTES; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MOLECULAR SEQUENCE DATA; RADIOIMMUNODETECTION;

ESCHERICHIA COLI; PROKARYOTA;

EID: 0032801482     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/027245799315899     Document Type: Article

References (29)

1. Oh YS, Lee JH, Kim SR, Chung HK, and Tchai BS: Production and characterization of monoclonal antibodies to carcinoembryonic antigen. Kor J Biochem 1988;20:43-48.
2. Choi CW, Chung JK, Lee DS, Lee MC, Chung HK, Kim BK, and Koh CS: Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody. Nucl Med Biol 1995;22:117-123.
3. Thomas P, Toth CA, Saini KS, Jessup JM, and Steele G, Jr: The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys Acta 1990;1032:177-189.
4. Arakawa F, Kuroki M, Misumi Y, Oikawa S, Nakazato H, and Matsuoka Y: Characterization of a cDNA clone encoding a new species of the nonspecific cross-reacting antigen (NCA), a member of the CEA gene family. Biochem Biophys Res Commun 1990;166:1063-1071.
5. Kuroki M, Matsuo Y, and Matsuoka Y: Nonspecific cross-reacting antigen (NCA) expressed by human granulocytes: Six species with different peptide sizes and membrane anchoring forms. Biochem Biophys Res Commun 1990;166:701-708.
6. Kuroki M, Arakawa F, Matsuo Y, Oikawa S, Misumi Y, Nakazato H, and Matsuoka Y: Molecular cloning of nonspecific cross-reacting antigens in human granulocytes. J Biol Chem 1991;266: 11810-11817.
7. Buchegger F, Schreyer M, Carrel S, and Mach JP: Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD. Int J Cancer 1984;33:643-649.
8. Reske SN, Karstens JH, Gloeckner W, Steinstrasser A, Schwarz A, Ammon J, and Buell U: Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989;1:299-301.
9. Seybold K, Locher JT, Coosemans C, Andres RY, Schubiger PA, and Blauenstein P: Immunoscintigraphic localization of inflammatory lesions: clinical experience. Eur J Nucl Med 1988;13: 587-593.
10. Dunker CM, Carrio I, Berna L, Estorch M, Alonso C, Ojeda B, Blanco R, Germa JR, and Ortega V: Radioimmune imaging of bone marrow in patients with suspected bone metastasis from primary breast cancer. J Nucl Med 1990;31:1450-1455.
11. Lind P, Langsteger W, Koltringer P, Dimai HP, Passl R, and Eber O: Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med 1990;31:417-423.
12. Cordes M, Hepp W, Barzen G and Langer R: Diagnostic evaluation of radioimmunoscintigraphy (RIS) with use of iodine 123-labeled antibodies against human granulocytes (123I-anti-NCA95) for the detection of prosthetic vascular graft infection [letter]. J Vasc Surg 1991;14:703-704.
13. Munz DL, Morguet AJ, Sandrock D, Heim A, Sold G, Figulla HR, Kreuzer H, and Emrich D: Radioimmunoimaging of subacute infective endocarditis using a technetium-99m monoclonal granulocyte-specific antibody. Eur J Nucl Med 1991;18:977-980.
14. Meller J, Ivancevic V, Conrad M, Gratz S, Munz DL, and Becker W: Clinical value of immunoscintigraphy in patients with fever of unknown origin. J Nucl Med 1998;39:1248-1253.
15. Thelen MH, Eschmann SM, Moll-Kotowski M, Dopfer R, and Bares R: Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis. J Nucl Med 1998;39:1033-1035.
16. Lee KH, Chung JK, Choi CW, Jeong JM, Lee DS, Bang YJ, Lee MC, Kim NK, and Koh CS: Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy. J Nucl Med 1995;36: 1800-1805.
17. Chung JK, Yeo J, Lee DS, Park S, Lee MC, Kim BK, and Koh CS: Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders [see comments]. J Nucl Med 1996;37:978-982.
18. Milenic DE, Yokota T, Filpula DR, Finkelman MA, Dodd SW, Wood JF, Whitlow M, Snoy P, and Schlom J: Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 1991;51:6363-6371.
19. Yokota T, Milenic DE, Whitlow M, and Schlom J: Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992;52:3402-3408.
20. Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, and Schlom J: Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms [published erratum appears in Cancer Res 1993;53:5832], Cancer Res 1993;53:3776-3783.
21. Hu S, Shively L, Raubitschek A, Sherman M, Williams LE, Wong JY, Shively JE, and Wu AM: Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res 1996;56:3055-3061.
22. Verhaar MJ, Keep PA, Hawkins RE, Robson L, Casey JL, Pedley B, Boden JA, Begent RH, and Chester KA: Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine. J Nucl Med 1996;37:868-872.
23. Pietersz GA, Patrick MR, and Chester KA: Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody. J Nucl Med 1998; 39:47-56.
24. Chung JH, Choi SJ, Kim HJ, Kim IJ, Choi IH, Lee SD, Yi KS, Suh PG, Ryu SH, and Chung HK: Cloning and characterization of cDNAs encoding VH and VL of a monoclonal anti-CEA antibody (CEA 79) cross-reactive with NCA-95 and generation of a single-chain Fv molecule (scFv). Mol Cells 1997;7:816-819.
25. McCaffety J, and Johnson KS: Construction and screening of antibody display libraries. In: Phage Display of Peptides and Proteins: A Laboratory Manual. Kay BK, Winter J, McCafferty J (Eds.). Academic Press, San Diego, 1996, pp. 79-112.
26. Djavadi-Ohaniance L, Goldberg ME, and Friguet B: Measuring antibody affinity in solution. In: Antibody Engineering: A Practical Approach. McCafferty J, Hoogenboom HR, Chiswell DJ (Eds.). Oxford University Press, New York, 1996, pp. 77-98.
27. Pember SO, Shapira R, and Kinkade JM, Jr: Multiple forms of myeloperoxidase from human neutrophilic granulocytes: Evidence for differences in compartmentalization, enzymatic activity, and subunit structure. Arch Biochem Biophys 1983;221: 391-403.
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227;680-685.
29. Bers G, and Garfin D: Protein and nucleic acid bloting and immunochemical detection. Biotechniques 1985;3:267-281.